Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2010
09/15/2010CN101829082A Method for preparing veterinary injection of spectinomycin hydrochloride and lincomycin hydrochloride
09/15/2010CN101829077A Application of dicaffeoyl-quinic acid derivative in preparing drugs for treating mycoplasma infection diseases
09/15/2010CN101829074A Standardized recombinant tea tree oil and preparing method thereof
09/15/2010CN101829070A Clarithromycin slow-release dispersible tablets and preparation method thereof
09/15/2010CN101829063A Lung targeting microsphere of veterinary ceftiofur hydrochloride and preparation method
09/15/2010CN101829060A Preparation method of clindamycin phosphate powder for injection
09/15/2010CN101829051A 1'-acetoxychavicol acetate injection
09/15/2010CN101829045A Azithromycin slow-release dry suspension and preparation method thereof
09/15/2010CN101829031A Preparation method of shampoo for pets
09/15/2010CN101828771A Calcium carbide liquid health-care clothes
09/15/2010CN101828713A Composition against infection with rotavirus and process for producing the same
09/15/2010CN101537009B Production process of compound preparation of ceftriaxone sodium and tazobactam sodium for injection
09/15/2010CN101440072B 4-tertiary butyl-6-aryl-2-6H-1,3-thiazine or salt thereof, as well as preparation method and application thereof
09/15/2010CN101322749B Chinese medicine oral liquid for treating wind-heat cold and preparation thereof
09/15/2010CN101214313B Medicament for treating chicken vibrio hepatitis
09/15/2010CN101181636B Compound vaccine composition for preventing and controlling human viral infection, compound vaccine vaginal mist and uses thereof
09/15/2010CN101167780B Antiviral compound Chinese medicinal herbs preparation for fish and shrimp
09/15/2010CN101108178B Application of cyclophilin A restrainer in preparing anti-virus medicament
09/15/2010CN101085048B Traditional Chinese medicine for detoxicating for animals and preparation method thereof
09/15/2010CN101066463B Staphylococcus aureau DNA vaccine pcDNA3.1(+)-Minigene and its preparation process
09/15/2010CN101049312B Composition of medication, preparation method and application
09/14/2010US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest
09/14/2010US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
09/14/2010US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14
09/14/2010US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides
09/14/2010US7795258 Pyridazine compound and use thereof
09/14/2010US7795244 of sulopenem, comprising 2-ethoxy-2-methyl-1-oxopropoxy)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[[(1R,3S)-tetrahydro-1-oxido-3-thienyl]thio]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate, used to treat and prevent bacterial infection in humans; antibiotics
09/14/2010US7795243 Penem prodrugs
09/14/2010US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases
09/14/2010US7794744 Nutritional modules
09/14/2010US7794735 Pathogen for bacterial poultry disease
09/14/2010US7794728 Induction immunology response; vaccines
09/14/2010US7794725 Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains
09/14/2010CA2594789C New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
09/14/2010CA2546910C Glycopeptide antibiotic derivatives
09/14/2010CA2521325C Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol
09/14/2010CA2487211C Pyrazolo(1,5a) pyrimidine compounds as antiviral agents
09/14/2010CA2464151C Ribavirin syrup formulations
09/14/2010CA2432009C Pharmaceutical preparations comprising a salt of an antibiotic and an antiphlogistic and use thereof
09/14/2010CA2416990C Nutritional composition
09/14/2010CA2343569C Mammalian transforming growth factor beta - 9
09/14/2010CA2294711C Novel polymeric compositions
09/14/2010CA2277911C Compounds and their combinations for the treatment of influenza infection
09/14/2010CA2261345C Feline polynucleotide vaccine formula
09/14/2010CA2260291C Antagonists of intestinotrophic glp-2 peptides
09/14/2010CA2166406C Recombinant swinepox virus
09/12/2010CA2658259A1 Dengue virus-like particle and uses thereof
09/10/2010WO2010102120A2 Methods and compositions to diagnose pain
09/10/2010WO2010101967A2 Phosphothiophene and phosphothiazole hcv polymerase inhibitors
09/10/2010WO2010101649A2 Sigma 1 receptor inhibition as a novel therapeutical approach against hepatitis c virus infection
09/10/2010WO2010101249A1 Method for enhancing function of t cell
09/10/2010WO2010101237A1 Polypeptides and antibacterial or antiseptic use of same
09/10/2010WO2010101061A1 Nucleoside-type antibiotic derivative
09/10/2010WO2010100252A1 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
09/10/2010WO2010100199A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/10/2010WO2010100186A1 Fluconazole carboxylic ester derivatives, synthesis, and use in long acting formulations
09/10/2010WO2010100178A1 Heterocyclic antiviral compounds
09/10/2010WO2010099938A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010WO2010099703A1 Novel uses of fibrinogen-420 and active domain thereof
09/10/2010WO2010099613A1 Plant extract compositions for prevention and treatment of influenza
09/10/2010WO2010099600A1 Compounds and methods for treating cancer and viral infections
09/10/2010WO2010099580A1 Treatment of infection
09/10/2010WO2010099576A1 Compositions and methods for enhancing immune responses
09/10/2010WO2010099573A1 Dioxolane norbornane / norbornene compounds suitable as antimicrobial agents to treat bacterial infections
09/10/2010WO2010075765A9 Cefdinir acid double salt and its preparation
09/10/2010WO2010062147A3 Crystal form of adefovir dipivoxil, preparation method thereof, and pharmaceutical composition containing the same
09/10/2010WO2010053877A3 Mhc ii associated protein and uses thereof
09/10/2010WO2010041279A4 Sustained release drug delivery system
09/10/2010WO2010032041A3 Antibacterial and/or anti-acne formulations containing salicylic acid or a derivative thereof
09/10/2010WO2007118986A8 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine
09/10/2010CA2754655A1 Novel antiviral agent
09/10/2010CA2754533A1 Treatment of infection
09/10/2010CA2754330A1 Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
09/10/2010CA2754064A1 Plant extract compositions for prevention and treatment of influenza
09/10/2010CA2753991A1 Secreted ap2 and methods of inhibiting same
09/10/2010CA2753638A1 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail
09/10/2010CA2752443A1 Heterocyclic antiviral compounds
09/09/2010US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/09/2010US20100227936 Treatment of microbial infections with compounds that inhibit 4-hydroxyphenylpyruvate dioxygenase
09/09/2010US20100227935 Class of terpene-derived compounds having an antibiotic activity, compositions containing the same and uses thereof
09/09/2010US20100227929 Transdermal compositions
09/09/2010US20100227926 Disinfectant Delivery System, and Method of Providing Alcohol-Free Disinfection
09/09/2010US20100227918 Streptomyces-derived antimicrobial compound and method of using same against antibiotic-resistant bacteria
09/09/2010US20100227915 Compositions and methods for inhibiting expression of a gene from the jc virus
09/09/2010US20100227899 Process for the treatment of bacterial infections using 2-phenyl-1,2-benzisoselenazol-3(2H)-one 1-oxide
09/09/2010US20100227892 Compounds, Compositions and Methods for Treatment and Prevention of Orthopoxvirus Infections and Associated Diseases
09/09/2010US20100227853 Inhibitors of cyclic amp phosphodiesterases
09/09/2010US20100227850 Methods for preventing and treating microbial infections by modulating transcription factors
09/09/2010US20100227843 Beta-lactamase-resistant cephalosporin ester compounds and salts of thereof
09/09/2010US20100227839 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin- 5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
09/09/2010US20100227835 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
09/09/2010US20100227834 Nucleosides for suppressing or reducing the development of resistance in cytostatic therapy
09/09/2010US20100227833 Novel nucleoside analogs for treatment of viral infections
09/09/2010US20100227813 increase the production of monocytic cells or moncyte cell progenitors by culturing bone marrow or blood cells with a polypeptide for use in treatment and prevention of viral hepatitis diseases; N-terminal methionine; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, systemic lupus, leukemia
09/09/2010US20100227808 Human kunitz-type inhibitor with enhanced antifibrinolytic activity
09/09/2010US20100227801 Pharmaceutical compositions
09/09/2010US20100227005 Methods to treat and/or prevent mucositis
09/09/2010US20100227002 Antioxidant compositions comprising extracts of myrtle and rosemary
09/09/2010US20100226990 Method of Producing Porous Microparticles
09/09/2010US20100226985 Viscoelastic aqueous gels comprising microspheres
1 ... 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 ... 1798